Clinical Trials Sponsored by Institute for Global Health Innovations

Total 3237 results

Barcelona Institute for Global Health

Completed

Maternal Diet, Body Mass Index Trajectories and Cardiometabolic Risk in Early Childhood

Growth | Childhood Obesity | Cardiometabolic Risk
Barcelona Institute for Global Health

Completed

Fatty Acids and Attention Deficit and Hyperactivity Disorder Symptoms

Attention Deficit Hyperactivity Disorder | Child Behavior Problem | Fatty Acid Deficiency
Barcelona Institute for Global Health

Completed

PHENOTYPE. Therapeutic Study in Barcelona

Poor Mental Health | Natural Outdoor Environments
Barcelona Institute for Global Health

Completed

Pregnant Women for Malaria Surveillance (MiPMon)

P. Falciparum
Centre for Global eHealth Innovation
University Health Network, Toronto; Trillium Health Partners

Unknown

Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalised Prostate Cancer Survivorship Care.

Prostate Cancer

Canada
Jhpiego
Barcelona Institute for Global Health

Completed

Evaluating the Effects of Community Delivery of Malaria Intermittent Preventive Treatment on Pregnant Women and Babies (TIPTOP)

Malaria in Pregnancy

Congo, The Democratic Republic of the, Madagascar, Mozambique, Nigeria
Barcelona Institute for Global Health
UNITAID

Active, not recruiting

Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) (BOHEMIA)

Malaria

Mozambique, Kenya
Jhpiego
Barcelona Institute for Global Health

Completed

TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study (TIPTOP-DRS)

Malaria in Pregnancy

Congo, The Democratic Republic of the, Madagascar, Mozambique, Nigeria
Barcelona Institute for Global Health
Carlos III Health Institute

Completed

Walnuts, Long-Chain Polyunsaturated Fatty Acids and Adolescent Brain Development (WALNUTs)

Neurobehavioral Manifestations | Vitamin/Nutritional Deficiency

Spain
Karolinska Institutet
The George Institute for Global Health, India

Not yet recruiting

ATLS vs Standard Care Trial

Wounds and Injuries
The George Institute for Global Health, China

Completed

Clinical Pathways for the Management of Acute Coronary Syndromes - Phase 3,CPACS-3 (CPACS-3)

Acute Coronary Syndromes

China
GSK Vaccines Institute For Global Health S.r.l.

Completed

Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults

Shigellosis

United Kingdom
The George Institute for Global Health, Australia

Completed

The Fluid Translation of Research Into Practice Study (Fluid-TRIPS)

Critical Care, Fluid Resuscitation

Australia
The George Institute for Global Health, China

Completed

Activating Media for Salt Reduction

Hypertensive Disease

China
The George Institute for Global Health, China

Completed

Rehabilitation for Disabled Stroke Patients in Rural China (RECOVER)

Stroke

China
The George Institute for Global Health, China

Completed

China Rural Health Initiative Follow up Study (CRHIFU)

Cardiovascular Disease

China
The George Institute for Global Health, Australia

Completed

Days Alive and Out of Hospital for Patients With Sepsis

Sepsis | Septic Shock

Australia
GSK Vaccines Institute For Global Health S.r.l.

Completed

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

Shigellosis

France
Medicines Development for Global Health

Completed

Dose-finding Study of Moxidectin for Treatment of Scabies

Scabies

Australia, Austria, France
Medicines Development for Global Health

Active, not recruiting

Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis

Onchocerciasis

Congo, The Democratic Republic of the
Medicines Development for Global Health

Recruiting

Efficacy and Safety Study of Moxidectin in Adults With Scabies

Scabies

United States, Honduras
Medicines Development for Global Health

Recruiting

Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole

Onchocerciasis

Côte D'Ivoire, Congo, The Democratic Republic of the
Medicines Development for Global Health

Completed

Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers

QT Effects in Healthy Volunteers

United States
Medicines Development for Global Health

Completed

A Pharmacokinetic and Safety Study of Moxidectin to Identify an Optimal Dose for Treatment of Children 4 to 11 Years

Onchocerciasis

Ghana
Duke University
Duke Institute for Health Innovation

Terminated

Hypertension Management in Cancer Patients

Hypertension | Cancer | Blood Pressure | Cancer, Breast | CLL | Cancer of Prostate | Hematopoietic Malignancy

United States
Duke University
Duke Institute for Health Innovation

Completed

Cancer Distress Coach Mobile App Trial

Cancer | Posttraumatic Stress Disorder

United States
Beijing Anzhen Hospital
The George Institute for Global Health, Australia; The George Institute for... and other collaborators

Recruiting

Cardiovascular Risk Reduction in Atrial Fibrillation Trial (CRAFT)

Hypertension | Atrial Fibrillation

China
Beijing Anzhen Hospital
The George Institute for Global Health, Australia; The George Institute for... and other collaborators

Recruiting

Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation (PROMPT-AF)

Persistent Atrial Fibrillation | Catheter Ablation

China
Swiss Tropical & Public Health Institute
Innovations for Poverty Action

Active, not recruiting

The Impact of PM+For Moms Intervention on Improving Mother's Mental Health in Zambia (PM+FM) (PM+FM)

Anxiety | Depressive Symptoms | Trauma, Psychological

Zambia
Swiss Tropical & Public Health Institute
Innovations for Poverty Action

Completed

Mobile Nudges to Increase Early Vaccination Coverage in Rural Areas (GEVaP)

Immunization Coverage

Ghana
The George Institute for Global Health, China
Changhai Hospital

Recruiting

Large Artery Occlusion Treated in Extended Time With Mechanical Thrombectomy Trial (LATE-MT)

Acute Ischemic Stroke

China
The George Institute for Global Health, China
Changhai Hospital

Terminated

Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2) (ENCHANTED2)

Acute Ischemic Stroke

China
Universidad Peruana Cayetano Heredia
Barcelona Institute for Global Health

Completed

Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 (SAINT-PERU)

Coronavirus Infection | Covid19 | SARS-CoV Infection

Peru
Duke University
The George Institute for Global Health, China

Completed

Weight Loss Among Adults in Beijing, China

Hypertension | Obesity

China
Craig Anderson
Johns Hopkins University; Genentech, Inc.; The George Institute for Global Health...

Recruiting

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

Acute Ischemic Stroke Patients Receiving Reperfusion Therapy

Australia, United Kingdom, United States, Chile, China, Malaysia, Mexico
Medicines Development for Global Health
World Health Organization

Completed

Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection

Onchocerciasis

Ghana
Medicines Development for Global Health
World Health Organization

Completed

Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection

Onchocerciasis

Congo, The Democratic Republic of the, Ghana, Liberia
Hospital Universitari Vall d'Hebron Research Institute
Barcelona Institute for Global Health

Completed

Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR) (CATCOVID-AIR)

Covid19 | Corona Virus Infection | Acute Respiratory Failure

Spain
Health Innovations, Frontier Research Institute

Terminated

A Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis C

Hepatitis C

United States
The George Institute for Global Health, China
National Health and Medical Research Council, Australia; Global Alliance for...

Completed

SMARTHealth Diabetes in China Using Lay Family Health Promoters

Hypertension | Diabetes Mellitus, Type 2 | Dyslipidemias

China
Lawson Health Research Institute
Pfizer; Canada Foundation for Innovation

Completed

Neuropathic Pain Database (NePDatabase)

Neuropathic Pain

Canada
MJHS Institute for Innovation in Palliative Care
Pfizer; The Institute for Family Health

Completed

Computerized Decision Support Tool for Pain Management in Primary Care

Chronic Pain
The George Institute for Global Health, China
Ningxia Medical University

Completed

NUTS for the Prevention of Cardiovascular Disease in Chinese Adults (NUTS)

Cardiovascular Diseases | Dyslipidemias

China
The George Institute for Global Health, China
Chinese Diabetes Society

Completed

Observational Registry for Basal Insulin Treatment Study (ORBIT)

Diabetes

China
University of Calgary
The George Institute for Global Health, Australia

Not yet recruiting

ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 (ACT-WHEN)

Acute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke Acute

Canada, Australia
Global Health Innovations
London School of Hygiene and Tropical Medicine; Kenya Medical Research Institute

Unknown

Utilizing the HITSystem for Optimizing Paediatric ART Retention and Adherence in Western Nyanza Province, Kenya (PARA)

Pediatric HIV Infection
University of Sydney
The George Institute for Global Health, India

Terminated

Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19 (CLARITY 2)

COVID-19 | SARS-CoV2 Infection

India
Imperial College Healthcare NHS Trust
The Behavioural Insights Team; Central London CCG; Imperial College Health Partners and other collaborators

Not yet recruiting

Using Text Messages to Improve COVID-19 Vaccination Uptake

Covid19
The George Institute for Global Health, China
National Heart, Lung, and Blood Institute (NHLBI)

Completed

High Cardiovascular Risk Management and Salt Reduction in Rural Villages in China

Cardiovascular Disease

China
Seattle Institute for Biomedical and Clinical Research
Puget Sound Partners for Global Health

Completed

Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder: A Pilot Study (MBSRforPTSD)

Depression | Stress Disorders, Post-Traumatic

United States

Clinical Trials Sponsored by Institute for Global Health Innovations

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations